Works matching Invasive tests


Results: 4977
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis.

    Published in:
    Liver International, 2024, v. 44, n. 8, p. 1872, doi. 10.1111/liv.15914
    By:
    • Mózes, Ferenc E.;
    • Lee, Jenny A.;
    • Vali, Yasaman;
    • Selvaraj, Emmanuel A.;
    • Jayaswal, Arjun N. A.;
    • Boursier, Jérôme;
    • de Lédinghen, Victor;
    • Lupșor‐Platon, Monica;
    • Yilmaz, Yusuf;
    • Chan, Wah‐Kheong;
    • Mahadeva, Sanjiv;
    • Karlas, Thomas;
    • Wiegand, Johannes;
    • Shalimar;
    • Tsochatzis, Emmanouil;
    • Liguori, Antonio;
    • Wong, Vincent Wai‐Sun;
    • Lee, Dae Ho;
    • Holleboom, Adriaan G.;
    • van Dijk, Anne‐Marieke
    Publication type:
    Article
    21
    22

    Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease.

    Published in:
    Cancers, 2023, v. 15, n. 6, p. 1659, doi. 10.3390/cancers15061659
    By:
    • Armandi, Angelo;
    • Caviglia, Gian Paolo;
    • Abdulle, Amina;
    • Rosso, Chiara;
    • Gjini, Kamela;
    • Castelnuovo, Gabriele;
    • Guariglia, Marta;
    • Perez Diaz del Campo, Nuria;
    • D'Amato, Daphne;
    • Ribaldone, Davide Giuseppe;
    • Saracco, Giorgio Maria;
    • Bugianesi, Elisabetta
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    NON INVASIVE PRENATAL TEST- PRESENT OR FUTURE.

    Published in:
    Journal of Perinatal Medicine, 2017, v. 45, p. 357, doi. 10.1515/jpm-2017-3002
    By:
    • Faika, Mujanović-Glamočanin;
    • Elda, Sijamija-Kišija;
    • Irma, Šabić
    Publication type:
    Article
    31
    32
    33
    34
    36
    37
    38
    39
    40
    41
    42

    Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277706
    By:
    • Grobbee, Esmée J.;
    • de Jong, Vivian D.;
    • Schrieks, Ilse C.;
    • Tushuizen, Maarten E.;
    • Holleboom, Adriaan G.;
    • Tardif, Jean-Claude;
    • Lincoff, A. Michael;
    • Schwartz, Gregory G.;
    • Castro Cabezas, Manuel;
    • Grobbee, Diederick E.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50